Exclusive

Publication

Byline

Location

US Patent Issued to Jyvaskylan yliopisto on April 14 for "Vemurafenib and salts thereof for use in the treatment of enteroviral infections" (Finnish Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,591, issued on April 14, was assigned to Jyvaskylan yliopisto (Jyvaskylan yliopisto, Finland). "Vemurafenib and salts thereof for use in t... Read More


US Patent Issued to Biomed Valley Discoveries on April 14 for "Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers" (Massachusetts, Missouri Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,593, issued on April 14, was assigned to Biomed Valley Discoveries Inc. (Kansas City, Mo.). "Methods and compositions for treating non-ERK... Read More


US Patent Issued to Amicus Therapeutics on April 14 for "Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones" (Pennsylvania, California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,595, issued on April 14, was assigned to Amicus Therapeutics Inc. (Philadelphia). "Dosing regimens for the treatment of lysosomal storage ... Read More


US Patent Issued to University of Kentucky Research Foundation on April 14 for "Substituted N-benzhydrylacetamide inhibitors of jumanji domain histone demethylases for the treatment of cancer" (Kentucky Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,597, issued on April 14, was assigned to University of Kentucky Research Foundation (Lexington, Ky.). "Substituted N-benzhydrylacetamide i... Read More


US Patent Issued to MEDICON PHARMACEUTICALS on April 14 for "Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof" (New York Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,599, issued on April 14, was assigned to MEDICON PHARMACEUTICALS INC. (Setauket, N.Y.). "Anti-inflammatory, anti-cancer, and anti-angiogen... Read More


US Patent Issued to Korea University Research and Business Foundation on April 14 for "Antifungal composition containing carbazole compound as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,601, issued on April 14, was assigned to Korea University Research and Business Foundation (Seoul, South Korea). "Antifungal composition c... Read More


US Patent Issued to INTRA-CELLULAR THERAPIES on April 14 for "Methods of treatment" (California, New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,603, issued on April 14, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.). "Methods of treatment" was invented by Peng Li ... Read More


US Patent Issued to NOVALIQ on April 14 for "Pharmaceutical compositions comprising timolol" (German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,607, issued on April 14, was assigned to NOVALIQ GMBH (Heidelberg, Germany). "Pharmaceutical compositions comprising timolol" was invented... Read More


US Patent Issued to Kowa on April 14 for "Methods of treating fuchs endothelial corneal dystrophy after descemetorhexis" (North Carolina, Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,609, issued on April 14, was assigned to Kowa Co. Ltd. (Nagoya, Japan). "Methods of treating fuchs endothelial corneal dystrophy after des... Read More


US Patent Issued to Neurelis on April 14 for "Methods and compositions for treating seizure disorders in pediatric patients" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,611, issued on April 14, was assigned to Neurelis Inc. (San Diego). "Methods and compositions for treating seizure disorders in pediatric ... Read More